Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
VanEck Vietnam ETF
VNM
$525M
| $2.81M | ﹤0.01% |
+145,874
| New | +$2.87M |
|
|
ECOM
3477
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $2.81M | ﹤0.01% |
111,412
-24,619
| -18% | -$607K |
|
|
FVAM
3478
DELISTED
5:01 Acquisition Corp
FVAM
| $2.81M | ﹤0.01% |
286,121
+10,122
| +4% | +$99K |
|
|
LAC
3479
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $2.8M | ﹤0.01% |
125,548
-368,442
| -75% | -$6.48M |
|
3480
Jacobs Solutions
J
$17.8B
| $2.8M | ﹤0.01% |
25,543
-25,771
| -50% | -$2.85M |
|
3481
PUT
Progyny
PGNY
$1.99B
| $2.8M | ﹤0.01% |
+50,000
| New | +$2.76M |
|
|
PSAG
3482
DELISTED
Property Solutions Acquisition Corporation II Class A Common Stock
PSAG
| $2.8M | ﹤0.01% |
289,596
+268,956
| +1,303% | +$2.59M |
|
3483
Apollo Global Management
APO
$79.7B
| $2.8M | ﹤0.01% |
45,452
-1,676,742
| -97% | -$101M |
|
|
NMMC
3484
DELISTED
North Mountain Merger Corp. Class A Common Stock
NMMC
| $2.8M | ﹤0.01% |
285,897
+250,000
| +696% | +$2.44M |
|
|
HONE
3485
DELISTED
HarborOne Bancorp
HONE
| $2.8M | ﹤0.01% |
199,219
+46,844
| +31% | +$649K |
|
3486
MGIC Investment
MTG
$6.36B
| $2.8M | ﹤0.01% |
186,951
-36,382
| -16% | -$527K |
|
3487
Corpay
CPAY
$26.8B
| $2.79M | ﹤0.01% |
10,690
-235,332
| -96% | -$60.9M |
|
3488
Twist Bioscience
TWST
$8.87B
| $2.79M | ﹤0.01% |
26,052
+7,463
| +40% | +$855K |
|
|
WOW
3489
DELISTED
WideOpenWest
WOW
| $2.79M | ﹤0.01% |
141,842
-213,747
| -60% | -$4.48M |
|
|
COOL
3490
DELISTED
Corner Growth Acquisition Corp. Class A Ordinary Shares
COOL
| $2.79M | ﹤0.01% |
285,384
+192,500
| +207% | +$1.87M |
|
3491
CALL
XPeng
XPEV
$11B
| $2.78M | ﹤0.01% |
78,200
| – | – |
|
|
GAMCU
3492
DELISTED
Golden Arrow Merger Corp. Unit
GAMCU
| $2.77M | ﹤0.01% |
280,258
+9,996
| +4% | +$99.1K |
|
|
LCI
3493
DELISTED
Lannett Company, Inc.
LCI
| $2.77M | ﹤0.01% |
231,135
-8,639
| -4% | -$140K |
|
3494
Gentherm
THRM
$1.21B
| $2.77M | ﹤0.01% |
34,234
+6,476
| +23% | +$513K |
|
3495
3D Systems Corp
DDD
$545M
| $2.77M | ﹤0.01% |
100,467
-119,006
| -54% | -$3.52M |
|
|
CLIM
3496
DELISTED
Climate Real Impact Solutions II Acquisition Corporation
CLIM
| $2.77M | ﹤0.01% |
283,216
-100,251
| -26% | -$977K |
|
|
CFV
3497
DELISTED
CF Acquisition Corp. V Class A Common Stock
CFV
| $2.77M | ﹤0.01% |
279,450
+119,451
| +75% | +$1.18M |
|
|
CKPT
3498
DELISTED
Checkpoint Therapeutics
CKPT
| $2.77M | ﹤0.01% |
83,818
-18,725
| -18% | -$553K |
|
|
VISN
3499
Vistance Networks Inc
VISN
$1.4B
| $2.76M | ﹤0.01% |
203,324
-423,349
| -68% | -$7.28M |
|
3500
Kforce
KFRC
$1.04B
| $2.76M | ﹤0.01% |
+46,331
| New | +$2.79M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.